KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Inventory (2016 - 2022)

TherapeuticsMD (TXMD) has disclosed Change in Inventory for 12 consecutive years, with $551000.0 as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Change in Inventory rose 49.73% year-over-year to $551000.0, compared with a TTM value of -$588000.0 through Sep 2022, down 2000.0%, and an annual FY2021 reading of $711000.0, down 78.69% over the prior year.
  • Change in Inventory was $551000.0 for Q3 2022 at TherapeuticsMD, up from -$2.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.0 million in Q3 2019 and bottomed at -$2.8 million in Q2 2022.
  • Average Change in Inventory over 5 years is $714490.1, with a median of $497644.0 recorded in 2018.
  • The sharpest move saw Change in Inventory soared 1145.66% in 2019, then crashed 1335.53% in 2022.
  • Year by year, Change in Inventory stood at $889449.0 in 2018, then soared by 49.29% to $1.3 million in 2019, then crashed by 136.07% to -$479000.0 in 2020, then surged by 154.28% to $260000.0 in 2021, then skyrocketed by 111.92% to $551000.0 in 2022.
  • Business Quant data shows Change in Inventory for TXMD at $551000.0 in Q3 2022, -$2.8 million in Q2 2022, and $1.4 million in Q1 2022.